Lialda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials

Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Condition: Ulcerative ColitisInterventions: Drug: Mesalamine; Drug: PlaceboSponsor: Ferring PharmaceuticalsNot yet recruiting - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2015 Category: Research Source Type: clinical trials

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
Condition: Colitis, UlcerativeInterventions: Drug: Mesalamine-Sodium Hyaluronic (IBD98-M ) High dose; Drug: Mesalamine-Sodium Hyaluronic (IBD98-M ) Low dose; Drug: Placebo:Sponsors: Holy Stone Healthcare Co. Ltd Healthcare Co. Ltd; inVentiv Health ClinicalNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2015 Category: Research Source Type: clinical trials